Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print August 22, 2002, doi: 10.1161/01.RES.0000034710.46739.C0
A more recent version of this article appeared on September 20, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/6/525    most recent
01.RES.0000034710.46739.C0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westfall, M. V.
Right arrow Articles by Metzger, J. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Westfall, M. V.
Right arrow Articles by Metzger, J. M.

Submitted on April 8, 2002
Revised on August 7, 2002
Accepted on August 12, 2002

Myofilament Calcium Sensitivity and Cardiac Disease. Insights From Troponin I Isoforms and Mutants

Margaret V. Westfall *; Andrea R. Borton ; Faris P. Albayya ; and Joseph M. Metzger

From the Departments of Surgery (M.V.W., A.R.B.) and Physiology (M.V.W., A.R.B., F.P.A., J.M.M.), School of Medicine, University of Michigan, Ann Arbor, Mich.

* To whom correspondence should be addressed. E-mail: wfall{at}w.imap.itd.umich.edu.

The heightened Ca2+ sensitivity of force found with the hypertrophic cardiomyopathy (HCM)-associated mutant cardiac troponin I (cTnIR145G; R146G in rodents) has been postulated to be an underlying cause of hypertrophic growth and premature sudden death in humans and in animals models of the disease. Expression of slow skeletal TnI (ssTnI), a TnI isoform naturally expressed in developing heart, also increases myofilament Ca2+ sensitivity, yet its expression in transgenic mouse hearts is not associated with overt cardiac disease. Gene transfer of TnI isoforms or mutants into adult cardiac myocytes is used here to ascertain if expression level or functional differences between HCM TnI and ssTnI could help explain these divergent organ-level effects. Results showed significantly reduced myofilament incorporation of cTnIR146G compared with ssTnI or wild-type cTnI. Despite differences in myofilament incorporation, ssTnI and cTnIR146G expression each resulted in enhanced myofilament tension in response to submaximal Ca2+ under physiological ionic conditions. Myofilament expression of an analogous HCM mutation in ssTnI (ssTnIR115G) did not further increase myofilament Ca2+ sensitivity of tension compared with ssTnI. In contrast, there was a divergent response under acidic pH conditions, a condition associated with the myocardial ischemia that often accompanies hypertrophic cardiomyopathy. The acidic pH-induced decrease in myofilament Ca2+ sensitivity was significantly greater in myocytes expressing cTnIR146G and ssTnIR115G compared with ssTnI. These results suggest that differences in pH sensitivities between wild-type ssTnI and mutant TnI proteins may be one factor in helping explain the divergent organ and organismal outcomes in TnI HCM and ssTnI mice.


Key words: troponin I • myofilament proteins • hypertrophic cardiomyopathy • heart




This article has been cited by other articles:


Home page
FASEB J.Home page
N. J. Palpant, L. G. D'Alecy, and J. M. Metzger
Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo
FASEB J, May 1, 2009; 23(5): 1529 - 1540.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wen, J. R. Pinto, A. V. Gomes, Y. Xu, Y. Wang, Y. Wang, J. D. Potter, and W. G. L. Kerrick
Functional Consequences of the Human Cardiac Troponin I Hypertrophic Cardiomyopathy Mutation R145G in Transgenic Mice
J. Biol. Chem., July 18, 2008; 283(29): 20484 - 20494.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S.-i. Yasuda, P. Coutu, S. Sadayappan, J. Robbins, and J. M. Metzger
Cardiac Transgenic and Gene Transfer Strategies Converge to Support an Important Role for Troponin I in Regulating Relaxation in Cardiac Myocytes
Circ. Res., August 17, 2007; 101(4): 377 - 386.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, G. M. Arteaga, R. John Solaro, S. B. Liggett, and D. F. Wieczorek
Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H949 - H958.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Davis, H. Wen, T. Edwards, and J. M. Metzger
Thin Filament Disinhibition by Restrictive Cardiomyopathy Mutant R193H Troponin I Induces Ca2+-Independent Mechanical Tone and Acute Myocyte Remodeling
Circ. Res., May 25, 2007; 100(10): 1494 - 1502.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kobayashi and R. J. Solaro
Increased Ca2+ Affinity of Cardiac Thin Filaments Reconstituted with Cardiomyopathy-related Mutant Cardiac Troponin I
J. Biol. Chem., May 12, 2006; 281(19): 13471 - 13477.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. V. Westfall, A. M. Lee, and D. A. Robinson
Differential Contribution of Troponin I Phosphorylation Sites to the Endothelin-modulated Contractile Response
J. Biol. Chem., December 16, 2005; 280(50): 41324 - 41331.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Sanbe, J. James, V. Tuzcu, S. Nas, L. Martin, J. Gulick, H. Osinska, S. Sakthivel, R. Klevitsky, K. S. Ginsburg, et al.
Transgenic Rabbit Model for Human Troponin I-Based Hypertrophic Cardiomyopathy
Circulation, May 10, 2005; 111(18): 2330 - 2338.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M Kruger, S Zittrich, C Redwood, N Blaudeck, J James, J Robbins, G Pfitzer, and R Stehle
Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils
J. Physiol., April 15, 2005; 564(2): 347 - 357.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Kedar, H. McDonough, R. Arya, H.-H. Li, H. A. Rockman, and C. Patterson
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
PNAS, December 28, 2004; 101(52): 18135 - 18140.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. M. Liou and J. C. H. Chang
Differential pH Effect on Calcium-Induced Conformational Changes of Cardiac Troponin C Complexed with Cardiac and Fast Skeletal Isoforms of Troponin I and Troponin T
J. Biochem., November 1, 2004; 136(5): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. A. Kass, J. G.F. Bronzwaer, and W. J. Paulus
What Mechanisms Underlie Diastolic Dysfunction in Heart Failure?
Circ. Res., June 25, 2004; 94(12): 1533 - 1542.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Layland, D. J. Grieve, A. C. Cave, E. Sparks, R J. Solaro, and A. M. Shah
Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically
J. Physiol., May 1, 2004; 556(3): 835 - 847.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. B. Marston and C. S. Redwood
Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins: Physiological and Pathological Implications
Circ. Res., December 12, 2003; 93(12): 1170 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Murphy
Troponin I: In Sickness and In Health--and Normal Development
Circ. Res., September 20, 2002; 91(6): 449 - 450.
[Full Text] [PDF]